New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis? [electronic resource]
Producer: 20101217Description: S217-27 p. digitalISSN:- 0399-8320
- Anti-Inflammatory Agents -- pharmacology
- Antibodies, Monoclonal -- pharmacology
- Biological Products -- therapeutic use
- Clinical Trials as Topic
- Colitis, Ulcerative -- therapy
- Crohn Disease -- therapy
- Drug Therapy, Combination
- Humans
- Inflammatory Bowel Diseases -- drug therapy
- Randomized Controlled Trials as Topic
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.